Report Overview
Immune globulin (Ig) short-term protection against hepatitis A and measles
The global Immune Globulins market size was estimated at USD 15220 million in 2023 and is projected to reach USD 29180.37 million by 2032, exhibiting a CAGR of 7.50% during the forecast period.
North America Immune Globulins market size was estimated at USD 4492.19 million in 2023, at a CAGR of 6.43% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Immune Globulins market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune Globulins Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune Globulins market in any manner.
Global Immune Globulins Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market Segmentation (by Type)
IVIg Liquid
IVIg Powder
Market Segmentation (by Application)
Immunodeficiency
Autoimmune Disease
Acute Infection
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Immune Globulins Market
� Overview of the regional outlook of the Immune Globulins Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune Globulins Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immune Globulins, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immune Globulins
1.2 Key Market Segments
1.2.1 Immune Globulins Segment by Type
1.2.2 Immune Globulins Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immune Globulins Market Overview
2.1 Global Market Overview
2.1.1 Global Immune Globulins Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Immune Globulins Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immune Globulins Market Competitive Landscape
3.1 Global Immune Globulins Sales by Manufacturers (2019-2025)
3.2 Global Immune Globulins Revenue Market Share by Manufacturers (2019-2025)
3.3 Immune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immune Globulins Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Immune Globulins Sales Sites, Area Served, Product Type
3.6 Immune Globulins Market Competitive Situation and Trends
3.6.1 Immune Globulins Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immune Globulins Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immune Globulins Industry Chain Analysis
4.1 Immune Globulins Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immune Globulins Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immune Globulins Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immune Globulins Sales Market Share by Type (2019-2025)
6.3 Global Immune Globulins Market Size Market Share by Type (2019-2025)
6.4 Global Immune Globulins Price by Type (2019-2025)
7 Immune Globulins Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immune Globulins Market Sales by Application (2019-2025)
7.3 Global Immune Globulins Market Size (M USD) by Application (2019-2025)
7.4 Global Immune Globulins Sales Growth Rate by Application (2019-2025)
8 Immune Globulins Market Consumption by Region
8.1 Global Immune Globulins Sales by Region
8.1.1 Global Immune Globulins Sales by Region
8.1.2 Global Immune Globulins Sales Market Share by Region
8.2 North America
8.2.1 North America Immune Globulins Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immune Globulins Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immune Globulins Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immune Globulins Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immune Globulins Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Immune Globulins Market Production by Region
9.1 Global Production of Immune Globulins by Region (2019-2025)
9.2 Global Immune Globulins Revenue Market Share by Region (2019-2025)
9.3 Global Immune Globulins Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Immune Globulins Production
9.4.1 North America Immune Globulins Production Growth Rate (2019-2025)
9.4.2 North America Immune Globulins Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Immune Globulins Production
9.5.1 Europe Immune Globulins Production Growth Rate (2019-2025)
9.5.2 Europe Immune Globulins Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Immune Globulins Production (2019-2025)
9.6.1 Japan Immune Globulins Production Growth Rate (2019-2025)
9.6.2 Japan Immune Globulins Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Immune Globulins Production (2019-2025)
9.7.1 China Immune Globulins Production Growth Rate (2019-2025)
9.7.2 China Immune Globulins Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Takeda
10.1.1 Takeda Immune Globulins Basic Information
10.1.2 Takeda Immune Globulins Product Overview
10.1.3 Takeda Immune Globulins Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda Immune Globulins SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 Grifols
10.2.1 Grifols Immune Globulins Basic Information
10.2.2 Grifols Immune Globulins Product Overview
10.2.3 Grifols Immune Globulins Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols Immune Globulins SWOT Analysis
10.2.6 Grifols Recent Developments
10.3 CSL
10.3.1 CSL Immune Globulins Basic Information
10.3.2 CSL Immune Globulins Product Overview
10.3.3 CSL Immune Globulins Product Market Performance
10.3.4 CSL Immune Globulins SWOT Analysis
10.3.5 CSL Business Overview
10.3.6 CSL Recent Developments
10.4 Octapharma
10.4.1 Octapharma Immune Globulins Basic Information
10.4.2 Octapharma Immune Globulins Product Overview
10.4.3 Octapharma Immune Globulins Product Market Performance
10.4.4 Octapharma Business Overview
10.4.5 Octapharma Recent Developments
10.5 Biotest
10.5.1 Biotest Immune Globulins Basic Information
10.5.2 Biotest Immune Globulins Product Overview
10.5.3 Biotest Immune Globulins Product Market Performance
10.5.4 Biotest Business Overview
10.5.5 Biotest Recent Developments
10.6 Kedrion
10.6.1 Kedrion Immune Globulins Basic Information
10.6.2 Kedrion Immune Globulins Product Overview
10.6.3 Kedrion Immune Globulins Product Market Performance
10.6.4 Kedrion Business Overview
10.6.5 Kedrion Recent Developments
10.7 Hualan Bio
10.7.1 Hualan Bio Immune Globulins Basic Information
10.7.2 Hualan Bio Immune Globulins Product Overview
10.7.3 Hualan Bio Immune Globulins Product Market Performance
10.7.4 Hualan Bio Business Overview
10.7.5 Hualan Bio Recent Developments
10.8 CNBG
10.8.1 CNBG Immune Globulins Basic Information
10.8.2 CNBG Immune Globulins Product Overview
10.8.3 CNBG Immune Globulins Product Market Performance
10.8.4 CNBG Business Overview
10.8.5 CNBG Recent Developments
10.9 Shanghai RAAS
10.9.1 Shanghai RAAS Immune Globulins Basic Information
10.9.2 Shanghai RAAS Immune Globulins Product Overview
10.9.3 Shanghai RAAS Immune Globulins Product Market Performance
10.9.4 Shanghai RAAS Business Overview
10.9.5 Shanghai RAAS Recent Developments
10.10 CBPO
10.10.1 CBPO Immune Globulins Basic Information
10.10.2 CBPO Immune Globulins Product Overview
10.10.3 CBPO Immune Globulins Product Market Performance
10.10.4 CBPO Business Overview
10.10.5 CBPO Recent Developments
10.11 LFB Group
10.11.1 LFB Group Immune Globulins Basic Information
10.11.2 LFB Group Immune Globulins Product Overview
10.11.3 LFB Group Immune Globulins Product Market Performance
10.11.4 LFB Group Business Overview
10.11.5 LFB Group Recent Developments
10.12 BPL
10.12.1 BPL Immune Globulins Basic Information
10.12.2 BPL Immune Globulins Product Overview
10.12.3 BPL Immune Globulins Product Market Performance
10.12.4 BPL Business Overview
10.12.5 BPL Recent Developments
10.13 Sichuan Yuanda Shuyang
10.13.1 Sichuan Yuanda Shuyang Immune Globulins Basic Information
10.13.2 Sichuan Yuanda Shuyang Immune Globulins Product Overview
10.13.3 Sichuan Yuanda Shuyang Immune Globulins Product Market Performance
10.13.4 Sichuan Yuanda Shuyang Business Overview
10.13.5 Sichuan Yuanda Shuyang Recent Developments
11 Immune Globulins Market Forecast by Region
11.1 Global Immune Globulins Market Size Forecast
11.2 Global Immune Globulins Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immune Globulins Market Size Forecast by Country
11.2.3 Asia Pacific Immune Globulins Market Size Forecast by Region
11.2.4 South America Immune Globulins Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Immune Globulins by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Immune Globulins Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Immune Globulins by Type (2025-2032)
12.1.2 Global Immune Globulins Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Immune Globulins by Type (2025-2032)
12.2 Global Immune Globulins Market Forecast by Application (2025-2032)
12.2.1 Global Immune Globulins Sales (K MT) Forecast by Application
12.2.2 Global Immune Globulins Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immune Globulins Market Size Comparison by Region (M USD)
Table 5. Global Immune Globulins Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Immune Globulins Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Immune Globulins Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Immune Globulins Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulins as of 2022)
Table 10. Global Market Immune Globulins Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Immune Globulins Sales Sites and Area Served
Table 12. Manufacturers Immune Globulins Product Type
Table 13. Global Immune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immune Globulins
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immune Globulins Market Challenges
Table 22. Global Immune Globulins Sales by Type (K MT)
Table 23. Global Immune Globulins Market Size by Type (M USD)
Table 24. Global Immune Globulins Sales (K MT) by Type (2019-2025)
Table 25. Global Immune Globulins Sales Market Share by Type (2019-2025)
Table 26. Global Immune Globulins Market Size (M USD) by Type (2019-2025)
Table 27. Global Immune Globulins Market Size Share by Type (2019-2025)
Table 28. Global Immune Globulins Price (USD/MT) by Type (2019-2025)
Table 29. Global Immune Globulins Sales (K MT) by Application
Table 30. Global Immune Globulins Market Size by Application
Table 31. Global Immune Globulins Sales by Application (2019-2025) & (K MT)
Table 32. Global Immune Globulins Sales Market Share by Application (2019-2025)
Table 33. Global Immune Globulins Sales by Application (2019-2025) & (M USD)
Table 34. Global Immune Globulins Market Share by Application (2019-2025)
Table 35. Global Immune Globulins Sales Growth Rate by Application (2019-2025)
Table 36. Global Immune Globulins Sales by Region (2019-2025) & (K MT)
Table 37. Global Immune Globulins Sales Market Share by Region (2019-2025)
Table 38. North America Immune Globulins Sales by Country (2019-2025) & (K MT)
Table 39. Europe Immune Globulins Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Immune Globulins Sales by Region (2019-2025) & (K MT)
Table 41. South America Immune Globulins Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Immune Globulins Sales by Region (2019-2025) & (K MT)
Table 43. Global Immune Globulins Production (K MT) by Region (2019-2025)
Table 44. Global Immune Globulins Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Immune Globulins Revenue Market Share by Region (2019-2025)
Table 46. Global Immune Globulins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Immune Globulins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Immune Globulins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Immune Globulins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Immune Globulins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Takeda Immune Globulins Basic Information
Table 52. Takeda Immune Globulins Product Overview
Table 53. Takeda Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Takeda Business Overview
Table 55. Takeda Immune Globulins SWOT Analysis
Table 56. Takeda Recent Developments
Table 57. Grifols Immune Globulins Basic Information
Table 58. Grifols Immune Globulins Product Overview
Table 59. Grifols Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Grifols Business Overview
Table 61. Grifols Immune Globulins SWOT Analysis
Table 62. Grifols Recent Developments
Table 63. CSL Immune Globulins Basic Information
Table 64. CSL Immune Globulins Product Overview
Table 65. CSL Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. CSL Immune Globulins SWOT Analysis
Table 67. CSL Business Overview
Table 68. CSL Recent Developments
Table 69. Octapharma Immune Globulins Basic Information
Table 70. Octapharma Immune Globulins Product Overview
Table 71. Octapharma Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Octapharma Business Overview
Table 73. Octapharma Recent Developments
Table 74. Biotest Immune Globulins Basic Information
Table 75. Biotest Immune Globulins Product Overview
Table 76. Biotest Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Biotest Business Overview
Table 78. Biotest Recent Developments
Table 79. Kedrion Immune Globulins Basic Information
Table 80. Kedrion Immune Globulins Product Overview
Table 81. Kedrion Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Kedrion Business Overview
Table 83. Kedrion Recent Developments
Table 84. Hualan Bio Immune Globulins Basic Information
Table 85. Hualan Bio Immune Globulins Product Overview
Table 86. Hualan Bio Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Hualan Bio Business Overview
Table 88. Hualan Bio Recent Developments
Table 89. CNBG Immune Globulins Basic Information
Table 90. CNBG Immune Globulins Product Overview
Table 91. CNBG Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. CNBG Business Overview
Table 93. CNBG Recent Developments
Table 94. Shanghai RAAS Immune Globulins Basic Information
Table 95. Shanghai RAAS Immune Globulins Product Overview
Table 96. Shanghai RAAS Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Shanghai RAAS Business Overview
Table 98. Shanghai RAAS Recent Developments
Table 99. CBPO Immune Globulins Basic Information
Table 100. CBPO Immune Globulins Product Overview
Table 101. CBPO Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. CBPO Business Overview
Table 103. CBPO Recent Developments
Table 104. LFB Group Immune Globulins Basic Information
Table 105. LFB Group Immune Globulins Product Overview
Table 106. LFB Group Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. LFB Group Business Overview
Table 108. LFB Group Recent Developments
Table 109. BPL Immune Globulins Basic Information
Table 110. BPL Immune Globulins Product Overview
Table 111. BPL Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. BPL Business Overview
Table 113. BPL Recent Developments
Table 114. Sichuan Yuanda Shuyang Immune Globulins Basic Information
Table 115. Sichuan Yuanda Shuyang Immune Globulins Product Overview
Table 116. Sichuan Yuanda Shuyang Immune Globulins Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Sichuan Yuanda Shuyang Business Overview
Table 118. Sichuan Yuanda Shuyang Recent Developments
Table 119. Global Immune Globulins Sales Forecast by Region (2025-2032) & (K MT)
Table 120. Global Immune Globulins Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Immune Globulins Sales Forecast by Country (2025-2032) & (K MT)
Table 122. North America Immune Globulins Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Immune Globulins Sales Forecast by Country (2025-2032) & (K MT)
Table 124. Europe Immune Globulins Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Immune Globulins Sales Forecast by Region (2025-2032) & (K MT)
Table 126. Asia Pacific Immune Globulins Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Immune Globulins Sales Forecast by Country (2025-2032) & (K MT)
Table 128. South America Immune Globulins Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Immune Globulins Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Immune Globulins Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Immune Globulins Sales Forecast by Type (2025-2032) & (K MT)
Table 132. Global Immune Globulins Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Immune Globulins Price Forecast by Type (2025-2032) & (USD/MT)
Table 134. Global Immune Globulins Sales (K MT) Forecast by Application (2025-2032)
Table 135. Global Immune Globulins Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Immune Globulins
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immune Globulins Market Size (M USD), 2019-2032
Figure 5. Global Immune Globulins Market Size (M USD) (2019-2032)
Figure 6. Global Immune Globulins Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immune Globulins Market Size by Country (M USD)
Figure 11. Immune Globulins Sales Share by Manufacturers in 2023
Figure 12. Global Immune Globulins Revenue Share by Manufacturers in 2023
Figure 13. Immune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immune Globulins Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immune Globulins Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immune Globulins Market Share by Type
Figure 18. Sales Market Share of Immune Globulins by Type (2019-2025)
Figure 19. Sales Market Share of Immune Globulins by Type in 2023
Figure 20. Market Size Share of Immune Globulins by Type (2019-2025)
Figure 21. Market Size Market Share of Immune Globulins by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immune Globulins Market Share by Application
Figure 24. Global Immune Globulins Sales Market Share by Application (2019-2025)
Figure 25. Global Immune Globulins Sales Market Share by Application in 2023
Figure 26. Global Immune Globulins Market Share by Application (2019-2025)
Figure 27. Global Immune Globulins Market Share by Application in 2023
Figure 28. Global Immune Globulins Sales Growth Rate by Application (2019-2025)
Figure 29. Global Immune Globulins Sales Market Share by Region (2019-2025)
Figure 30. North America Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Immune Globulins Sales Market Share by Country in 2023
Figure 32. U.S. Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Immune Globulins Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Immune Globulins Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Immune Globulins Sales Market Share by Country in 2023
Figure 37. Germany Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Immune Globulins Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Immune Globulins Sales Market Share by Region in 2023
Figure 44. China Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Immune Globulins Sales and Growth Rate (K MT)
Figure 50. South America Immune Globulins Sales Market Share by Country in 2023
Figure 51. Brazil Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Immune Globulins Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Immune Globulins Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Immune Globulins Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Immune Globulins Production Market Share by Region (2019-2025)
Figure 62. North America Immune Globulins Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Immune Globulins Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Immune Globulins Production (K MT) Growth Rate (2019-2025)
Figure 65. China Immune Globulins Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Immune Globulins Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Immune Globulins Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Immune Globulins Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Immune Globulins Market Share Forecast by Type (2025-2032)
Figure 70. Global Immune Globulins Sales Forecast by Application (2025-2032)
Figure 71. Global Immune Globulins Market Share Forecast by Application (2025-2032)
